Add to ORKGOBJECTIVE: The objective of this systematic review is to determine whether or not besifloxacin ophthalmic suspension 0.6% is safe and effective for the treatment of bacterial conjunctivitis
Background/purposeTo date, studies examining polymicrobial infections in ocular disease have mostly ...
Objective: Ocular inserts offer many advantages over conventional dosage forms, like increased ocula...
PURPOSE: To summarize key findings from a Cochrane Review of the benefits and safety of antibiotic t...
OBJECTIVE: The objective of this systematic review is to determine whether or not besifloxacin ophth...
Introduction: Acute bacterial conjunctivitis is one of the most common ocular infection seen in day ...
Besifloxacin is fourth generation ophthalmic fluoroquinolone of synthetic origin, it was approved by...
The Author(s) 2013. This article is published with open access at Springerlink.com Background Besifl...
BACKGROUND: Bacterial conjunctivitis is an inflammation of the conjunctiva is defined as conjuncti...
Purpose: The aim of the study was to evaluate the safety of besifloxacin ophthalmic suspension 0.6 %...
Lorenzo J Cervantes, Francis S MahDepartment of Ophthalmology, Cornea and External Disease, Universi...
Summary: A study was conducted to determine the safety and efficacy of topically applied ciprofloxac...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
Frank A Bucci Jr,1 Ruth E Evans,1 Loretta M Amico,1 Timothy W Morris,2 Angel T Fluet,1 Christine M S...
Background: Pefloxacin is a newer broad-spectrum bactericidal fluoroquinolone antibiotic, with super...
Steven A Nielsen,1 Marguerite B McDonald,2 Parag A Majmudar31Nielsen Eye Center, Quincy, MA, USA; 2O...
Background/purposeTo date, studies examining polymicrobial infections in ocular disease have mostly ...
Objective: Ocular inserts offer many advantages over conventional dosage forms, like increased ocula...
PURPOSE: To summarize key findings from a Cochrane Review of the benefits and safety of antibiotic t...
OBJECTIVE: The objective of this systematic review is to determine whether or not besifloxacin ophth...
Introduction: Acute bacterial conjunctivitis is one of the most common ocular infection seen in day ...
Besifloxacin is fourth generation ophthalmic fluoroquinolone of synthetic origin, it was approved by...
The Author(s) 2013. This article is published with open access at Springerlink.com Background Besifl...
BACKGROUND: Bacterial conjunctivitis is an inflammation of the conjunctiva is defined as conjuncti...
Purpose: The aim of the study was to evaluate the safety of besifloxacin ophthalmic suspension 0.6 %...
Lorenzo J Cervantes, Francis S MahDepartment of Ophthalmology, Cornea and External Disease, Universi...
Summary: A study was conducted to determine the safety and efficacy of topically applied ciprofloxac...
This is an open access article. Unrestricted non-commercial use is permitted provided the original w...
Frank A Bucci Jr,1 Ruth E Evans,1 Loretta M Amico,1 Timothy W Morris,2 Angel T Fluet,1 Christine M S...
Background: Pefloxacin is a newer broad-spectrum bactericidal fluoroquinolone antibiotic, with super...
Steven A Nielsen,1 Marguerite B McDonald,2 Parag A Majmudar31Nielsen Eye Center, Quincy, MA, USA; 2O...
Background/purposeTo date, studies examining polymicrobial infections in ocular disease have mostly ...
Objective: Ocular inserts offer many advantages over conventional dosage forms, like increased ocula...
PURPOSE: To summarize key findings from a Cochrane Review of the benefits and safety of antibiotic t...